Trial Profile
Effect of Perioperative Iron Isomaltoside 1000 Administration on Transfusion Requirements in Patients Undergoing Complex Valvular Heart Surgery: a Randomized Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2022
Price :
$35
*
At a glance
- Drugs Ferric derisomaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 01 Feb 2022 Primary endpoint (the proportion of patients who need blood transfusion) has not been met, according to Results published in the Annals of Surgery.
- 01 Feb 2022 Results published in the Annals of Surgery
- 21 May 2020 Status changed from recruiting to completed.